HomeNewsBusinessIPOCapillary Technologies shares surge 8% on debut day after listing at 3% discount to IPO price

Capillary Technologies shares surge 8% on debut day after listing at 3% discount to IPO price

Capillary Technologies share price: The Rs 877.5-crore IPO saw strong investor interest during its three days of public bidding, being subscribed nearly 53 times from November 14-18.

November 21, 2025 / 16:11 IST
Story continues below Advertisement
Capillary Technologies listing ceremony at BSE
Capillary Technologies listing ceremony at BSE

The shares of Capillary Technologies made a weak debut on stock markets on November 21, listing at Rs 560 apiece on BSE. This marks a discount of 2.95 percent over the IPO price of Rs 577 apiece.

The market capitalization of the company stood at over Rs 4,400 crore at debut. On NSE, the shares listed with a lower discount of 0.88 percent at Rs 571.90 apiece.

Story continues below Advertisement

The stock then surged significantly, erasing all listing losses. The shares of the company rose 8.38 percent from its listing price to close at Rs 606.90 apiece on BSE. This marks a rise of 5.18 percent from the IPO price. Its market cap at the end of the debut day stood at Rs 4,813.43 crore.

This comes after the Rs 877.5-crore IPO of Capillary Technologies, which offers artificial intelligence-based cloud-native Software-as-a-Service (SaaS) products and solutions, saw strong investor interest during its three days of public bidding.

The maiden public issue of the company got subscribed nearly 53 times its offer size (5,295 percent) between November 14 and November 18. Qualified Institutional Buyers (QIB) showed the most interest, subscribing their reserved portion over 57 times. Retail portion was booked around 16 times.

Capillary Technologies IPO GMP:


The listing performance has significantly missed grey market expectations. Ahead of listing, the unlisted shares of the company were trading with 9.53 percent grey market premium (GMP) over the IPO price, according to data on Investorgain.